Global Antisense & RNAi Therapeutics Market Research Report 2022: Analysis of Oncology, Cardiovascular Diseases, Respiratory Disorders, Neurological Disorders, & Infectious Diseases
21 juin 2022 04h23 HE
|
Research and Markets
Dublin, June 21, 2022 (GLOBE NEWSWIRE) -- The "Antisense & RNAi Therapeutics Global Market Report 2022: By Technology, By Route, By Indication" report has been added to ResearchAndMarkets.com's...
The Worldwide RNA Based Therapeutic Industry is Expected to Reach $11.4 Billion by 2027
24 mai 2022 06h58 HE
|
Research and Markets
Dublin, May 24, 2022 (GLOBE NEWSWIRE) -- The "Global RNA Based Therapeutic Market By Type, By Application, By End User, By Regional Outlook, Industry Analysis Report and Forecast, 2021-2027" report...
Global RNAi Market Therapeutics Market (2022 to 2035) - by Key Therapeutic Areas, Route of Administration, Leading Industry Players, Type of RNAi Molecule and Key Geographical Regions
16 mai 2022 07h28 HE
|
Research and Markets
Dublin, May 16, 2022 (GLOBE NEWSWIRE) -- The "RNAi Market: Therapeutics and Technologies by Key Therapeutic Areas, Route of Administration, Leading Industry Players, Type of RNAi Molecule and Key...
Outlook on the RNA Based Therapeutic Global Market to 2030 - Multifactorial Disease Targeting Presents Opportunities
28 avr. 2022 06h43 HE
|
Research and Markets
Dublin, April 28, 2022 (GLOBE NEWSWIRE) -- The "RNA Based Therapeutic Market by Disease Type, Application and End User: Global Opportunity Analysis and Industry Forecast, 2021-2030" report has been...
Global RNAi Therapeutics Market Insights & Forecast Report 2022-2026: Rising Utilization in Oncology Pharmaceuticals & Progress in Collaborations and Associated Deals in RNAi Therapeutics
21 avr. 2022 04h43 HE
|
Research and Markets
Dublin, April 21, 2022 (GLOBE NEWSWIRE) -- The "Global RNAi Therapeutics Market (by Molecule Type, Application, End-User & Region): Insights & Forecast with Potential Impact of COVID-19...
Global RNAi Therapeutics Market Research Report 2022: Industry Analysis, Trends, Market Size, and Forecasts, 2019-2027
11 avr. 2022 08h18 HE
|
Research and Markets
Dublin, April 11, 2022 (GLOBE NEWSWIRE) -- The "RNAi Therapeutics Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2027" report has been added to ResearchAndMarkets.com's...
Global RNAi Therapeutics Market Report 2022-2026: Analysis by Molecule Type - Small Interference RNA (siRNA), and Micro RNA (miRNA)
08 avr. 2022 06h23 HE
|
Research and Markets
Dublin, April 08, 2022 (GLOBE NEWSWIRE) -- The "Global RNAi Therapeutics Market: Analysis By Molecule Type, By Application, By Region Size and Trends with Impact of COVID-19 and Forecast up to 2026"...
Worldwide RNA Interference (RNAi) Drug Delivery Industry to 2027 - Players Include Alnylam Pharmaceuticals, Arrowhead Pharmaceuticals and CureVac Among Others
08 mars 2022 07h13 HE
|
Research and Markets
Dublin, March 08, 2022 (GLOBE NEWSWIRE) -- The "Worldwide RNA Interference (RNAi) Drug Delivery" report has been added to ResearchAndMarkets.com's offering. The global RNA interference (RNAi) drug...
Global RNA Stabilization & Delivery Technology Advances Market Report 2021: LNP- and Bioconjugation-based Nonviral RNA Delivery Technologies to Gain Momentum in the Next 3 Years
15 févr. 2022 05h43 HE
|
Research and Markets
Dublin, Feb. 15, 2022 (GLOBE NEWSWIRE) -- The "Technological Advances in RNA Stabilization & Delivery" report has been added to ResearchAndMarkets.com's offering. RNA therapeutics is a rapidly...
Silence Therapeutics Welcomes Deep Track Capital as New Shareholder
01 déc. 2021 07h00 HE
|
Silence Therapeutics plc
1 December 2021 LONDON, Silence Therapeutics plc, Nasdaq: SLN (“Silence” or “the Company”), a leader in the discovery, development and delivery of novel short interfering ribonucleic acid (siRNA)...